Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Skinvisible (SKVI) over the last 17 years, with Q3 2025 value amounting to $5.4 million.

  • Skinvisible's Shares Outstanding (Weighted Average) rose 1903.15% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 1903.15%. This contributed to the annual value of $5.1 million for FY2024, which is 1148.73% up from last year.
  • Skinvisible's Shares Outstanding (Weighted Average) amounted to $5.4 million in Q3 2025, which was up 1903.15% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, Skinvisible's Shares Outstanding (Weighted Average) ranged from a high of $5.4 million in Q2 2025 and a low of $4.5 million during Q1 2021
  • For the 5-year period, Skinvisible's Shares Outstanding (Weighted Average) averaged around $4.7 million, with its median value being $4.5 million (2021).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first changed by 0.0% in 2022, then soared by 1903.15% in 2025.
  • Over the past 5 years, Skinvisible's Shares Outstanding (Weighted Average) (Quarter) stood at $4.5 million in 2021, then changed by 0.0% to $4.5 million in 2022, then changed by 0.0% to $4.5 million in 2023, then rose by 11.49% to $5.1 million in 2024, then rose by 6.77% to $5.4 million in 2025.
  • Its last three reported values are $5.4 million in Q3 2025, $5.4 million for Q2 2025, and $5.4 million during Q1 2025.